The study of OAT3 inhibitors can help us predict and avoid potential OAT3-mediated DDIs/HDIs [69], and these inhibitors may also have potentially beneficial effects on renal diseases, such as AAI-induced kidney disease [70]. The gene discussed is SLC22A8; the disease is kidney disorder.